Question 1

Who are the top researchers at GlycoMimetics (United States)?

Accepted Answer

Ranked on the quality score, John L. Magnani, William E. Fogler and Helen M Thackray lead among researchers whose main affiliation is GlycoMimetics (United States).

Question 2

What are the most cited papers from GlycoMimetics (United States)?

Accepted Answer

The most cited paper from GlycoMimetics (United States) is "Vascular niche E-selectin regulates hematopoietic stem cell dormancy, self renewal and chemoresistance" (Ingrid G. Winkler, Valérie Barbier, Bianca Nowlan et al., 2012), with 434 citations. Next come "Bone vascular niche E-selectin induces mesenchymal–epithelial transition and Wnt activation in cancer cells to promote bone metastasis" (269) and "Dormant breast cancer micrometastases reside in specific bone marrow niches that regulate their transit to and from bone" (244).

Question 3

Which research topics does GlycoMimetics (United States) publish most on?

Accepted Answer

By volume in 2022-now: Cell Adhesion Molecules Research, Angiogenesis and VEGF in Cancer, Acute Myeloid Leukemia Research and S100 Proteins and Annexins.

Question 4

Which keywords describe research at GlycoMimetics (United States)?

Accepted Answer

By fractional works in all years, weighted toward what it does more of than the world: Inflammation, Cancer, Angiogenesis, Extracellular Matrix, Cell Adhesion, Integrins, Therapeutic Targets and Cell Migration.

Question 5

Which fields of science does GlycoMimetics (United States) work in?

Accepted Answer

In all years, 62% of research at GlycoMimetics (United States) is in Health Sciences, 35% in Life Sciences. Its largest fields are Medicine (62%), Biochemistry, Genetics and Molecular Biology (25%), Immunology and Microbiology (10%). It does 2.3× the world's share of Health Sciences.

Question 6

Is GlycoMimetics (United States)'s research output growing?

Accepted Answer

Output in 2022-2025 was 89% lower than in 2018-2021.